Injection treatment for lymphatic malformations in children
Treatments studied
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This trial tests two different injections (bleomycin vs doxycycline) to see which works better for shrinking large or mixed lymphatic malformations in children. It's a first treatment option for young children who haven't had any prior therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 0 and 12 years old.
- The lymphatic malformation must be macrocytic (large cysts) or mixed (large and small cysts).
- Your child has not had any prior sclerotherapy or surgery for the malformation.
- Your child has no known allergy to bleomycin or doxycycline.
- There is no active infection at the site of the malformation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medicine called bleomycin, injected into lymphatic malformations (abnormal fluid-filled growths) to shrink them. It is for children under 14 whose malformations are growing quickly, causing symptoms or problems, and cannot be removed by surgery alone.
This trial tests a treatment called bleomycin electrosclerotherapy (BEST) for low-flow vascular malformations—abnormal blood vessel or lymph vessel growths that haven't responded well to previous treatments. The treatment involves injecting bleomycin (a medication) directly into the malformation and using electrical current to help destroy it.
This study is testing a treatment called electrosclerotherapy for low-flow venous malformations. It uses a medicine (bleomycin) injected into the abnormal blood vessels to shrink them. The goal is to see how well it works and how safe it is.
This trial studies a treatment approach for children and teens newly diagnosed with lymphoblastic lymphoma. It may help doctors choose therapies based on genetic risk information from lab testing done on tumor samples.
This Phase 2 trial tests whether an injected medicine called TARA-002 placed inside lymphatic cysts can safely shrink lymphatic malformations in children. It may help especially when the cysts are mainly in the head, neck, or chest area.
This trial tests different doses of sirolimus (a medication that slows cell growth) to find the best dose for treating cystic lymphatic malformations in children. It may help shrink the abnormal fluid-filled growths and improve symptoms.
Hear when a new Lymphatic Abnormality trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.